NYSE: XOMExxon Mobil Corp Stock
$116.40-0.93 (-0.79%)
Updated Sep 20, 2023
XOM Price
$116.40
Fair Value Price
N/A
Market Cap
$465.97B
52 Week Low
$83.89
52 Week High
$119.92
P/E
9.31x
P/B
2.34x
P/S
1.15x
PEG
N/A
Dividend Yield
3.13%
Revenue
$376.98B
Earnings
$51.72B
Gross Margin
27.6%
Operating Margin
19.1%
Profit Margin
13.7%
Debt to Equity
0.79
Operating Cash Flow
$68B
Beta
0.9
Next Earnings
Oct 26, 2023
Ex-Dividend
N/A
Next Dividend
N/A
XOM Overview
Exxon Mobil Corporation is an integrated energy company operating through Upstream, Downstream, and Chemical segments. The company sells crude oil, natural gas, petroleum products, petrochemicals, and other specialty products; manufactures and sells petrochemicals, including olefins, polyolefins, aromatics, and various other petrochemicals; and captures and stores carbon, hydrogen, and biofuels. As of 2021/12/31, it had approximately 20,52 wells with proved reserves.The company was founded in 1870 and is headquartered in Irving, TX.
Zen Score
–
Industry Average (42)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XOM scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XOM is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XOM is good value based on its earnings relative to its share price (9.31x), compared to the US market average (14.54x)
P/E vs Market Valuation
XOM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more XOM due diligence checks available for Premium users.
Be the first to know about important XOM news, forecast changes, insider trades & much more!
XOM News
Valuation
XOM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
9.31x
Industry
7.83x
Market
14.54x
XOM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
XOM is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
XOM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.34x
Industry
1.67x
XOM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XOM's financial health
Profit margin
Revenue
$82.9B
Net Income
$7.9B
Profit Margin
9.5%
XOM's Earnings (EBIT) of $72.02B... subscribe to Premium to read more.
Interest Coverage Financials
XOM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$363.2B
Liabilities
$156.3B
Debt to equity
0.79
XOM's short-term assets ($91.76B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XOM's long-term liabilities ($94.44B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XOM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XOM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$9.4B
Investing
-$4.4B
Financing
-$8.2B
XOM's operating cash flow ($67.77B)... subscribe to Premium to read more.
Debt Coverage Financials
XOM vs Oil & Gas Integrated Stocks
Exxon Mobil Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.